Question from Deputy Ken O'Flynn - PQ 36450-26
Deputy O'Flynn asked if a review has been undertaken into the drivers of variation in average reimbursement cost per salbutamol nebule item.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked if a review has been undertaken into the drivers of variation in average reimbursement cost per salbutamol nebule item.
Deputy McGettigan asked about the safeguards to prevent inappropriate sharing or coordination of inaccurate patient information. Read the HSE response.
Deputy McGettigan asked about the circumstances under which a clinician is referred to the relevant regulatory body following a complaint. Read the HSE response
Deputy O'Flynn asked if there is a central register of high cost procedures approved under the Treatment Abroad Scheme. Read the HSE response.
Deputy O'Flynn asked about governance pathways for the Treatment Abroad Scheme. Read the HSE response.
Deputy O'Flynn asked about monetary approval thresholds within the treatment abroad scheme. Read the HSE response.
Deputy O'Flynn asked about the value for money assessment process under the treatment abroad scheme. Read the HSE response.
Deputy Smith asked about the criteria applicable for access to respite services. Read the HSE response.
Deputy Boland asked about the number of registrars in nephrology based at Beaumont Hospital. Read the HSE response.
Deputy O'Flynn asked about applications under the Treatment Abroad Scheme that have been refused on financial grounds. Read the HSE response.